by Team Small News | Jan 5, 2026 | Lupin, Pharma
PolyPeptide, a leading manufacturer of peptides, has formed a strategic alliance with Lupin Manufacturing Solutions. The partnership aims to establish a framework for long-term cooperation, focusing on integrated procurement and supply planning for select raw... by Team Small News | Dec 4, 2025 | Lupin, Pharma
The pharmaceutical company, Lupin, is reportedly in discussions to acquire Vitabiotics, a UK-based vitamins and supplements manufacturer, in a deal estimated to be worth £1 billion (approximately Rs 11,800 crore). Vitabiotics is a family-owned brand, founded by the... by Team Small News | Nov 28, 2025 | Lupin, Pharma
The Golden Cross is a technical indicator that suggests a trend reversal from bearish to bullish, occurring when the 50-day moving average (DMA) moves above the 200 DMA. For Lupin, a pharmaceutical company, this event may mark the beginning of a recovery phase after a... by Team Small News | Nov 15, 2025 | Lupin, Pharma
Lupin Limited, a global pharmaceutical company, has achieved a significant milestone by securing an S&P Global ESG Score of 91 for 2025. This score places the company among a select group of pharmaceutical organizations that have crossed the 90-point threshold,... by Team Small News | Nov 10, 2025 | Lupin, Pharma
Lupin, a leading pharmaceutical company, has unveiled its ambitious product pipeline and strategic targets, showcasing its commitment to driving growth and innovation in the industry. The company has outlined a robust pipeline of new products and formulations, aimed... by Team Small News | Nov 8, 2025 | Lupin, Pharma
The Lupin Bioresearch Center, a prominent research facility, has achieved a significant milestone by receiving zero observations from the United States Food and Drug Administration (USFDA) following a successful inspection and assessment. This impressive feat...